Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hermans

Showing results (171-180 of 188) with videos related to

Pageof 19
Sort By:
Journal of Thrombosis and Haemostasis : JTH|December 3, 2014
The novel ADAMTS13-p.D187H mutation impairs ADAMTS13 activity and secretion and contributes to thrombotic thrombocytopenic purpura in miceE De Cock, C Hermans, J De Raeymaecker, et al.
Anaesthesia|February 11, 2017
Ultrasound-guided approach to nerves (direct vs. tangential) and the incidence of intraneural injection: a cadaveric studyL A Sermeus, X Sala-Blanch, J G McDonnell, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 21, 2011
Patient- and physician-level determinants of blood pressure response to treatment in normal weight and overweight patients (the PREVIEW study)I Abraham, K MacDonald, M Song, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2000
Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma GroupA Le Cesne, I Judson, D Crowther, et al.
Respiratory Medicine|July 22, 2009
"Real-life" effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST studyG Brusselle, A Michils, R Louis, et al.
Scientific Reports|November 4, 2025
Reliability and state-dependency of EEG connectivity, complexity and network characteristicsL S Dominicus, D Y Lodema, B Oranje, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 28, 2017
Target plasma factor levels for personalized treatment in haemophilia: a Delphi consensus statementA Iorio, E Iserman, V Blanchette, et al.
Journal of Thrombosis and Haemostasis : JTH|April 26, 2017
Intensity of factor VIII treatment and the development of inhibitors in non-severe hemophilia A patients: results of the INSIGHT case-control studyA S van Velzen, C L Eckhardt, M Peters, et al.
European Journal of Cancer (Oxford, England : 1990)|April 21, 2001
Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma GroupI Judson, J A Radford, M Harris, et al.
European Journal of Cancer (Oxford, England : 1990)|March 31, 2000
Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma GroupO S Nielsen, I Judson, Q van Hoesel, et al.
Pageof 19

Showing results (171-180 of 188) with videos related to

Sort By:
Pageof 19
Journal of Thrombosis and Haemostasis : JTH|December 3, 2014
The novel ADAMTS13-p.D187H mutation impairs ADAMTS13 activity and secretion and contributes to thrombotic thrombocytopenic purpura in miceE De Cock, C Hermans, J De Raeymaecker, et al.
Anaesthesia|February 11, 2017
Ultrasound-guided approach to nerves (direct vs. tangential) and the incidence of intraneural injection: a cadaveric studyL A Sermeus, X Sala-Blanch, J G McDonnell, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 21, 2011
Patient- and physician-level determinants of blood pressure response to treatment in normal weight and overweight patients (the PREVIEW study)I Abraham, K MacDonald, M Song, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2000
Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma GroupA Le Cesne, I Judson, D Crowther, et al.
Respiratory Medicine|July 22, 2009
"Real-life" effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST studyG Brusselle, A Michils, R Louis, et al.
Scientific Reports|November 4, 2025
Reliability and state-dependency of EEG connectivity, complexity and network characteristicsL S Dominicus, D Y Lodema, B Oranje, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 28, 2017
Target plasma factor levels for personalized treatment in haemophilia: a Delphi consensus statementA Iorio, E Iserman, V Blanchette, et al.
Journal of Thrombosis and Haemostasis : JTH|April 26, 2017
Intensity of factor VIII treatment and the development of inhibitors in non-severe hemophilia A patients: results of the INSIGHT case-control studyA S van Velzen, C L Eckhardt, M Peters, et al.
European Journal of Cancer (Oxford, England : 1990)|April 21, 2001
Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma GroupI Judson, J A Radford, M Harris, et al.
European Journal of Cancer (Oxford, England : 1990)|March 31, 2000
Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma GroupO S Nielsen, I Judson, Q van Hoesel, et al.
Pageof 19